Moshe Manor, President & CEO at Protalix BioTherapeutics, Inc. (PLX), bought 50,000 shares at $0.81 ($41K) on 2017-05-16, disclosed to the SEC on 2017-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.